Related Experiment Video

Updated: May 21, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

[Renal insufficiency and cardiovascular diseases]

S Kücükköylü1, L C Rump

  • 1Klinik für Nephrologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. kuecuekk@uni-duesseldorf.de

Der Internist
|June 12, 2012
PubMed

Insights

Chronic kidney disease (CKD) significantly increases cardiovascular risk. Early interventions like blood pressure control and proteinuria reduction are crucial for managing cardiovascular outcomes in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Context:

  • Chronic kidney disease (CKD) is a major risk factor for cardiovascular disease (CVD).
  • Microalbuminuria serves as an early marker for both renal and cardiac damage.
  • CKD patients exhibit increased cardiovascular morbidity and mortality.

Purpose:

  • To highlight the importance of optimal blood pressure management and proteinuria reduction in CKD patients.
  • To emphasize the inadequate secondary prevention strategies currently employed in CKD care.
  • To underscore the need for screening and managing sleep-related disorders to improve cardiovascular outcomes.

Summary:

  • Optimal blood pressure therapy and proteinuria reduction are key to mitigating cardiovascular risks in CKD.
  • Secondary prevention strategies are underutilized in CKD patients.
  • Screening for and treating sleep disorders may improve cardiovascular health in CKD.
  • Further research is needed on novel therapies like oral anticoagulants and transcatheter aortic valve implantation in advanced CKD and dialysis patients.

Impact:

  • Improved cardiovascular outcomes for patients with chronic kidney disease.
  • Enhanced understanding of the cardiovascular risks associated with CKD.
  • Identification of gaps in current secondary prevention strategies for CKD patients.
  • Guidance for future research into advanced therapeutic approaches for CKD.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...